Donoghoe Nicholas 4
4 · AbbVie Inc. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
AbbVie EVP Nicholas Donoghoe Sells 12,874 Shares for Tax Withholding
What Happened
- Nicholas Donoghoe, Executive Vice President & Chief Business/Strategy Officer at AbbVie (ABBV), had 12,874 shares disposed on Feb 27, 2026 at $232.08 per share for a total of $2,987,798. The Form 4 lists the transaction code "F," indicating the shares were surrendered to satisfy tax withholding related to an equity award or option event (a disposition rather than a voluntary open-market sale).
Key Details
- Transaction date: 2026-02-27
- Price per share: $232.08; Shares disposed: 12,874; Gross value: $2,987,798
- Transaction code: F (payment of exercise price or tax liability — typically shares withheld to cover taxes)
- Filing date / accession: Form 4 filed 2026-03-03 (filed within the SEC’s two-business-day deadline)
- Shares owned after transaction: not specified in the provided summary filing
Context
- This was a tax-withholding disposition (common after option exercises or vesting). Such withholdings are routine administrative actions to cover tax obligations and are not the same as a discretionary open-market sale that might signal an insider view of the stock. The filing appears timely under SEC Form 4 rules.
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Transactions
- Tax Payment
Common Stock, $0.01 par value
2026-02-27$232.08/sh−12,874$2,987,798→ 74,430 total
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Nicholas J. Donoghoe|2026-03-03